Zentalis Pharmaceuticals (ZNTL) Prepaid Assets (2019 - 2026)

Zentalis Pharmaceuticals' Prepaid Assets history runs 8 years deep, the most recent figure standing at $6.3 million for Q1 2026.

• On a quarterly basis, Prepaid Assets fell 53.97% year-over-year to $6.3 million in Q1 2026; TTM through Mar 2026 was $6.3 million, a 53.97% decrease from a year earlier, with the FY2025 full-year figure at $7.3 million, down 26.89% from the prior year.
• Prepaid Assets declined to $6.3 million in Q1 2026 per ZNTL's latest filing, from $7.3 million in the prior quarter.
• Across five years, Prepaid Assets topped out at $27.2 million in Q1 2023 and bottomed at $6.3 million in Q1 2026.
• The 5-year median for Prepaid Assets is $12.2 million (2022), against an average of $13.8 million.
• Across the five-year window, Prepaid Assets soared 107.65% in 2022 and plunged 59.31% in 2025, its largest moves.
• Year by year, Prepaid Assets stood at $14.6 million in 2022, then soared by 41.58% to $20.6 million in 2023, then plunged by 51.58% to $10.0 million in 2024, then retreated by 26.89% to $7.3 million in 2025, then fell by 13.15% to $6.3 million in 2026.
• Per Business Quant, the three latest ZNTL Prepaid Assets figures stand at $6.3 million (Q1 2026), $7.3 million (Q4 2025), and $7.6 million (Q3 2025).